Vilin Bio Med Limited (NSEI: VILINBIO)
Salud · Farmacéuticas · IN
52,90 Rs
+1,83 % hoy · +126,6 % 1 año
Vilin Bio Med Limited (NSEI: VILINBIO) opera en la industria de farmacéuticas dentro del sector salud. Su valor en bolsa es de 8,56 M $ y tiene 14 empleados.
En los últimos doce meses la acción ha subido un 126,6 % y ha cotizado entre 18,95 y 60,95.
Tweenvest puntúa a Vilin Bio Med Limited en cuatro factores: calidad 64/100, valor 57/100, crecimiento 87/100. Su punto más fuerte es crecimiento.
Evolución de la cotización de VILINBIO
Cifras clave
- Capitalización
- 8,56 M $
- Ingresos (últ. 12 m)
- 4,51 M $
- PER
- 41,98
- BPA
- 1,26
- Rent. por dividendo
- —
- Beta (5 años)
- 0,68
- Máximo 52 semanas
- 60,95 Rs
- Mínimo 52 semanas
- 18,95 Rs
- Volumen medio (3 m)
- —
- Acciones en circulación
- 15,25 M
- Empleados
- 14
- Próximos resultados
- —
Sobre Vilin Bio Med Limited
Vilin Bio Med Ltd. is a domestic pharmaceutical company primarily engaged in the manufacturing and trading of pharmaceutical products, with a focus on generic formulations across various therapeutic segments. The company produces pharmaceutical formulations such as oral liquids, dry syrups, sachets, external preparations, beta and non-beta lactam tablets and capsules, and nutritional food supplements. These products address therapeutic areas including anti-infectives, analgesics, cardiovascular, musculoskeletal, antibiotic, central nervous system, alimentary system, genito-urinary tract, respiratory system, anti-allergic, and anti-diabetic conditions. Vilin Bio Med also engages in contract manufacturing and the distribution of its own branded generics, supplying products in bulk to pharmaceutical manufacturers, marketers, and traders. Beyond pharmaceuticals, the company offers a range of cosmetics, including products for baby care, skin care, oral care, and hair care, such as serums, oils, lotions, creams, cleansers, moisturizers, and masks. The primary target market for Vilin Bio Med is the domestic Indian market, which generates over 90% of its revenue, though it also has international operations and a U.S. subsidiary for marketing and distribution in the United States, alongside a presence in GCC, Africa, EU, and Asia.
- ISIN
- INE0L4V01013
- Fundada en
- 2005
- Cotiza desde
- 30 jun 2023
- Bolsa
- National Stock Exchange of India
- Divisa
- INR
Otras empresas de farmacéuticas
| Empresa | Capitalización | Precio | Día |
|---|---|---|---|
| Daré Bioscience, Inc.NasdaqCM: DARE | 8,85 M $ | 0,45 $ | +4,90 % |
| OncoZenge AB (publ)OM: ONCOZ | 8,75 M $ | 3,20 Skr | -1,39 % |
| Mediplantex National Pharmaceutical Joint Stock CompanyHNX: MED | 8,70 M $ | 18.000,00 ₫ | 0,00 % |
| Rekvina Laboratories LimitedBSE: 526075 | 8,56 M $ | 72,62 Rs | +1,99 % |
| Vitura Health LimitedASX: VIT | 8,49 M $ | 0,02 AU$ | -5,00 % |
| Shelter Pharma LimitedBSE: 543963 | 8,43 M $ | 47,08 Rs | +0,49 % |
| CalciMedica, Inc.NasdaqCM: CALC | 8,26 M $ | 1,21 $ | -0,82 % |
| Central Pharmaceuticals Ltd.DSE: CENTRALPHL | 8,23 M $ | 8,60 Tk | -1,15 % |